ConductScience.org, home

Paper76797

Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.

Johnstone EC and 4 others. Lancet, 1978. Cited by 377 papers, by iCite.

Cite this record

ConductScience Library. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Papers, record 76797. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/76797

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.
PubMed
Journal
Lancet
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
377
iCite
Relative citation ratio, by iCite
14.8
iCite
Revised in PubMed
2022-03-11
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Johnstone ECE C
2Crow TJT J
3Frith CDC D
4Carney MWM W
5Price JSJ S

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FlupenthixolMajor topic
SchizophreniaMajor topic
ThioxanthenesMajor topic
Acute Disease
Adolescent
Adult
Chlorpromazine
Clinical Trials as Topic
Drug Evaluation
Drug Therapy, Combination
Female
Humans
Isomerism
Male
Placebos
Receptors, Dopamine
Research Design

Source PubMed

Download CSV of topics

Cited by77

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 377 citations.

PMIDTitleJournalYearIn PapersSource
40109883Seminal Contributions of Timothy J. Crow.Psychol Med2025https://conductscience.org/library/papers/40109883PubMed
38172494Alterations of serum neuropeptide levels and their relationship to cognitive impairment and psychopathology in male patients with chronic schizophrenia.Schizophrenia (Heidelb)2024https://conductscience.org/library/papers/38172494PubMed
37196827Dual orexin/hypocretin receptor antagonism attenuates NMDA receptor hypofunction-induced attentional impairments in a rat model of schizophrenia.Behav Brain Res2023https://conductscience.org/library/papers/37196827PubMed
36880665Consciousness, (meta)cognition, and culture.Q J Exp Psychol (Hove)2023https://conductscience.org/library/papers/36880665PubMed
36700319Effects of Long-acting Injectable 3-Monthly Paliperidone Palmitate on the Clinical and Social Performance of Patients with Schizophrenia.Clin Psychopharmacol Neurosci2023https://conductscience.org/library/papers/36700319PubMed
35894865Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial.Int J Neuropsychopharmacol2022https://conductscience.org/library/papers/35894865PubMed
34518523Differential dopamine release by psychosis-generating and non-psychosis-generating addictive substances in the nucleus accumbens and dorsomedial striatum.Transl Psychiatry2021https://conductscience.org/library/papers/34518523PubMed
33340975Motor-related oscillatory activity in schizophrenia according to phase of illness and clinical symptom severity.Neuroimage Clin2021https://conductscience.org/library/papers/33340975PubMed
32803162Quantifying the Core Deficit in Classical Schizophrenia.Schizophr Bull Open2020https://conductscience.org/library/papers/32803162PubMed
32166169The development of antipsychotic drugs.Brain Neurosci Adv2018https://conductscience.org/library/papers/32166169PubMed
31434513The Core Deficit of Classical Schizophrenia: Implications for Predicting the Functional Outcome of Psychotic Illness and Developing Effective Treatments.Can J Psychiatry2019https://conductscience.org/library/papers/31434513PubMed
31214054Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia.Front Psychiatry2019https://conductscience.org/library/papers/31214054PubMed
30758785Dopamine in psychiatry: a historical perspective.J Neural Transm (Vienna)2019https://conductscience.org/library/papers/30758785PubMed
30038229A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter.Mol Psychiatry2020https://conductscience.org/library/papers/30038229PubMed
29213544Clozapine for severe ("kraepelinian") schizophrenia: Sustained improvement over 5 years.Dement Neuropsychol2008https://conductscience.org/library/papers/29213544PubMed
25184047Recent advances in understanding schizophrenia.F1000Prime Rep2014https://conductscience.org/library/papers/25184047PubMed
25177834Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/25177834PubMed
24915451Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24915451PubMed
24560140Implications of cellular models of dopamine neurons for schizophrenia.Prog Mol Biol Transl Sci2014https://conductscience.org/library/papers/24560140PubMed
24395698Chlorpromazine versus placebo for schizophrenia.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24395698PubMed

See all 77 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/76797

GET https://conductscience.org/api/papers/v1/76797/cited_by?page=2